Hematologist-Oncologist: Kenneth Micetich, MD | Loyola Medicine

Kenneth Micetich, MD

Kenneth Micetich, MD


Program Director, Institutional Review Board (IRB)

Languages Spoken

Patient Ratings
4.9 / 5 (53 Ratings)

Clinical Expertise

  • Gastrointestinal Stromal Tumor (GIST)
  • Lung Cancer

About Dr. Micetich


Medical Education

Medical School
Loyola University Chicago Stritch School of Medicine
Loyola University Medical Center - Internal Medicine: General
  • Loyola University Medical Center - Internal Medicine: Medical Oncology
  • National Cancer Institute (NCI) - Internal Medicine: Medical Oncology

Board Certification

American Board of Internal Medicine
American Board of Internal Medicine Subspecialty Medical Oncology


  • Four hundred fifty-three consecutive pancreaticoduodenectomies with pancreaticogastrostomy. Eguia, E; O'Halloran, EA; Borge, MA; Micetich, K; Aranha, GV, American Journal of Surgery
  • SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma Ben-Josef, E.; Guthrie, K. A.; El-Khoueiry, A. B.; Corless, C. L.; Zalupski, M. M.; Lowy, A. M.; Thomas, C. R., Jr; Alberts, S. R.; Dawson, L. A.; Micetich, K. C.; Thomas, M. B.; Siegel, A. B.; Blanke, C. D., Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • S0941: a phase 2 SWOG study of sorafenib and erlotinib in patients with advanced gallbladder carcinoma or cholangiocarcinoma El-Khoueiry, A. B.; Rankin, C.; Siegel, A. B.; Iqbal, S.; Gong, I. Y.; Micetich, K. C.; Kayaleh, O. R.; Lenz, H. J.; Blanke, C. D., British journal of cancer
View All ResearchShow Less
  • The depth of post-treatment perirectal tissue invasion is a predictor of outcome in patients with clinical T3N1M0 rectal cancer treated with neoadjuvant chemoradiation followed by surgical resection Brandt, W. S.; Yong, S.; Abood, G.; Micetich, K.; Walther, A.; Shoup, M., American Journal of Surgery
  • Sweet's syndrome with neurologic manifestations in a patient with esophageal adenocarcinoma: case report and review of the literature Sobol, Urszula A.; Sherman, Karen L.; Smith, Jason; Nagda, Suneel N.; Micetich, K. C.; Nickoloff, Brian J.; Shoup, M. C., International journal of dermatology
  • Is artificial nutrition and hydration extraordinary care? Micetich, K. C., The virtual mentor : VM
  • Analysis of signal transducer and activator of transcription 3 (STAT3) in gastrointestinal stromal tumors. Paner, G. P.; Silberman, S.; Hartman, G.; Micetich, K. C.; Aranha, G. V.; Alkan, S., Anticancer Research
  • Competing clinical trials in the same institution: ethical issues in subject selection and informed consent Gordon, E. J.; Micetich, K. C., Irb
  • Long-term survival of a patient with widespread metastases from Barrett's adenocarcinoma Mason, G. R.; Micetich, K.; Aranha, G. V., European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology